Antibacterial Agents TRIZ Cases

Attenuated Fc binding eliminates Protein A interference, reducing kidney burden and enhancing antibody-dependent killing.

Lyophilized multi-antigen composition stabilizes ClfA and MntC proteins for reliable immune response induction.

An anion-depleted platelet lysate formulation eliminates antimicrobial-tolerant biofilms and reduces bacterial loads in infectious arthritis.

Bi(hetero)aryl residues in bradykinin-B1 antagonists improve pharmacological properties, addressing suboptimal activity in simpler structures.

Substituted piperidine compounds inhibit KDM2b to deplete cancer stem cells, addressing inadequate gene regulation control.

Solid effervescent composition delivers lactic bacteria via rapid dissolution, overcoming oily capsule barriers that inhibit colonization.

Formula I compounds inhibit bromodomains, addressing limited treatment options for cancer and immunological disorders.

Hybrid benzimidazole-hydantoin compounds bypass existing drug resistance mechanisms by targeting multiple microorganisms through novel structural parameters.

Lac-GAP-3 bacteriophage eliminates Lactococcus garvieae via targeted lysis, avoiding antibiotic resistance and environmental pollution.

Alpha,alpha-disubstituted amino carboxylic acid compounds bind tightly to the arginase enzyme active site, addressing abnormally high arginase activity.

Fc-modified antibodies bind neutrophil extracellular traps to prevent lysis, reducing toxic degradation products and bleeding risks.

Shear stress applied to immobilized bacteria reveals antibiotic susceptibility without growth phases.

Single cross-reactive antibodies block both interleukin-17A and interleukin-17F, reducing treatment complexity compared to separate therapies.

Modular triazole synthesis combats resistant pathogens by segmenting complex manufacturing into optimized stages.

Targeting the Rv3671c membrane protease with serine hydrolase inhibitors disrupts acid resistance to treat drug-resistant tuberculosis.

Novel tricyclic compounds inhibit riboflavin synthase, restoring antibacterial efficacy against multidrug-resistant Salmonella enterica.

Cross-linked silyl polymers resolve the trade-off between rapid drug delivery speed and prolonged therapeutic effect in transdermal patches.

Conjugating factor H binding protein with cholera toxin subunit B overcomes factor H interference to enhance protective immune responses.

Targeted antibodies bind CXCR7 epitopes to modulate angiogenesis while reducing validation complexity.

Novel tetrahydropyrimidine methanone derivatives overcome multidrug-resistant Mycobacterium tuberculosis through distinct molecular mechanisms.

Antisense molecules hybridize to Staphylococcus aureus ribosomal protein coding regions, inhibiting MRSA growth despite delivery challenges.

A vaccine formulation method adsorbs hepatitis B surface antigen onto aluminium oxyhydroxide while keeping Haemophilus influenzae type b antigen non-adsorbed.

Hydroxyalkyl-substituted imidazo[4,5-d]thiazole compounds induce interferon-alpha biosynthesis while suppressing tumor necrosis factor-alpha production.

Segmented beads connected by suture material provide defined antibiotic release periods, preventing drug-resistant bacterial growth in high-velocity wounds.

Combines killed Lawsonia bacteria with PCV2 ORF2 protein for intradermal swine immunization.

Novel anti-ROBO4 antibody activates downstream signaling pathways to inhibit vascular endothelial cell migration and suppress angiogenesis.

Hydroxamic acid derivatives inhibit the LpxC enzyme to block Lipid A biosynthesis, overcoming antibiotic resistance in Gram-negative infections.

Segmented SACOL antigens from the COL genome elicit targeted immunity, reducing bacterial counts and preventing relapses in bovine mastitis.

Quaternized sugar-derived surfactants provide stable foam and skin compatibility in antimicrobial formulations.

A water-based comestible composition with natural ingredients reduces plaque and tartar in animals.

Modifying benzimidazolium structures reduces permeability while extending activity duration for airway disease treatment.

Segmented hyaluronan fragments substitute N-acetyl groups to enhance receptor binding while reducing pro-inflammatory cytokine production.

Methanesulfonic acid composition removes biofilms without invasive surgery, reducing infection risk.

Hydantoin compounds simultaneously block MMPs, TACE, and TNF-alpha production to prevent cartilage degradation in osteoarthritis.

D-retro-inverso amino acid modifications resist kinase phosphorylation, stabilizing JNK inhibitors against inactivation.

Tailoring triazole and hydroxamic acid structures to optimize binding affinity while maintaining selectivity against human metalloenzymes.

Kukoamine A and B isolate specific alkaloids from Lycii cortex to neutralize LPS, resolving unclear mechanisms in traditional medicine.

Adoptive T cells constitutively express costimulatory ligands like CD80 to resolve the bottleneck of absent tumor costimulation in prostate cancer therapy.

Gene-modified plasmacytoid dendritic cells prime tumor-specific cytotoxic T lymphocytes to generate robust immunity against diverse diseases.

Phenyl ring linkers display carbohydrate epitopes to recruit natural antibodies, improving therapeutic efficacy against cancer and infectious diseases.

HPTP-beta inhibitors modulate angiogenesis to resolve inadequate tissue repair in cancer and chronic wound treatments.

Novel quinuclidinol derivatives reduce systemic side effects while maintaining therapeutic effect through extended duration of action.

Chemical synthesis of defined glycan structures avoids tedious bacterial isolation, ensuring purity and stability for vaccine production.

Quick freezing liquid vaccine formulations into dry powder eliminates refrigeration needs while maintaining antigenic potency and ease of administration.

Aqueous acid precipitation yields amorphous Ertapenem intermediates with high purity and storage stability, eliminating organic solvent use.

Stereoselective conversion of allylic ketones to amino acid keto epoxides for potent proteasome inhibition.